RPPA analysis revealed significant levels of HER2<sup>Total</sup> in PDAC patients at abundances comparable to HER2-positive (IHC 3+) and HER2-low (IHC 1+ /2+ , FISH-) breast cancer tissues, for which HER2 screening is routinely performed. The gene discussed is ERBB2; the disease is breast carcinoma.